These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 37842910)

  • 1. Treatment Initiation, Substance Use Trajectories, and the Social Determinants of Health in Persons Living With HIV Seeking Medication for Opioid Use Disorder.
    Cook RR; Jaworski EN; Hoffman KA; Waddell EN; Myers R; Korthuis PT; Vergara-Rodriguez P
    Subst Abus; 2023 Oct; 44(4):301-312. PubMed ID: 37842910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short communication: Relationship between social determinants and opioid use disorder treatment outcomes by gender.
    Parlier-Ahmad AB; Radic M; Svikis DS; Martin CE
    Drug Alcohol Depend; 2022 Mar; 232():109337. PubMed ID: 35123364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Effectiveness Associated With Buprenorphine and Naltrexone in Opioid Use Disorder and Cooccurring Polysubstance Use.
    Xu KY; Mintz CM; Presnall N; Bierut LJ; Grucza RA
    JAMA Netw Open; 2022 May; 5(5):e2211363. PubMed ID: 35536575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Medication for Opioid Use Disorder Among US Adolescents and Adults With Need for Opioid Treatment, 2019.
    Mauro PM; Gutkind S; Annunziato EM; Samples H
    JAMA Netw Open; 2022 Mar; 5(3):e223821. PubMed ID: 35319762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Availability of Medications for the Treatment of Opioid Use Disorder Among Pregnant and Postpartum Individuals in US Jails.
    Sufrin C; Kramer CT; Terplan M; Fiscella K; Olson S; Voegtline K; Latkin C
    JAMA Netw Open; 2022 Jan; 5(1):e2144369. PubMed ID: 35050354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Sick and tired of being sick and tired": Exploring initiation of medications for opioid use disorder among people experiencing homelessness.
    Swartz N; Adnan T; Peréa F; Baggett TP; Chatterjee A
    J Subst Abuse Treat; 2022 Jul; 138():108752. PubMed ID: 35277306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A National Study of Homelessness, Social Determinants of Health, and Treatment Engagement Among Outpatient Medication for Opioid Use Disorder-Seeking Individuals in the United States.
    Gaeta Gazzola M; Carmichael ID; Christian NJ; Zheng X; Madden LM; Barry DT
    Subst Abus; 2023; 44(1):62-72. PubMed ID: 37226909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlates of days of medication for opioid use disorder exposure among people living with HIV in Northern Vietnam.
    Button D; Cook R; King C; Khuyen TT; Kunkel L; Bart G; Thuy DT; Nguyen DB; Blazes CK; Giang LM; Korthuis PT
    Int J Drug Policy; 2022 Feb; 100():103503. PubMed ID: 34768124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating opioid use disorder in veterans with co-occurring substance use: a qualitative study with buprenorphine providers in primary care, mental health, and pain settings.
    Frost MC; Soyer EM; Achtmeyer CE; Hawkins EJ; Glass JE; Hallgren KA; Williams EC
    Addict Sci Clin Pract; 2023 May; 18(1):26. PubMed ID: 37143162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication Treatment of Active Opioid Use Disorder in Veterans With Cirrhosis.
    Rogal S; Youk A; Agbalajobi O; Zhang H; Gellad W; Fine MJ; Belperio P; Morgan T; Good CB; Kraemer K
    Am J Gastroenterol; 2021 Jul; 116(7):1406-1413. PubMed ID: 33811202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between fentanyl use and initiation, persistence, and retention on medications for opioid use disorder among people living with uncontrolled HIV disease.
    Cook RR; Torralva R; King C; Lum PJ; Tookes H; Foot C; Vergara-Rodriguez P; Rodriguez A; Fanucchi L; Lucas GM; Waddell EN; Korthuis PT
    Drug Alcohol Depend; 2021 Nov; 228():109077. PubMed ID: 34600253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Social Determinants of Health and Continuity of Medications for Opioid Use Disorder Among Patients Receiving Treatment in Rural Primary Care Settings.
    Pham H; Ober A; Baldwin LM; Mooney LJ; Zhu Y; Fei Z; Hser YI
    J Addict Med; 2024 May-Jun 01; 18(3):331-334. PubMed ID: 38315721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community.
    Biondi BE; Vander Wyk B; Schlossberg EF; Shaw A; Springer SA
    Addict Sci Clin Pract; 2022 Mar; 17(1):15. PubMed ID: 35255967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial and ethnic disparities in medication for opioid use disorder access, use, and treatment outcomes in Medicare.
    Gibbons JB; McCullough JS; Zivin K; Brown ZY; Norton EC
    J Subst Use Addict Treat; 2024 Feb; 157():209271. PubMed ID: 38135120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incarceration and compulsory rehabilitation impede use of medication for opioid use disorder and HIV care engagement in Vietnam.
    King C; Cook R; Giang LM; Bart G; Hoffman K; Waddell EN; Korthuis PT
    J Subst Abuse Treat; 2022 Mar; 134():108451. PubMed ID: 33962813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial inequity in medication treatment for opioid use disorder: Exploring potential facilitators and barriers to use.
    Hollander MAG; Chang CH; Douaihy AB; Hulsey E; Donohue JM
    Drug Alcohol Depend; 2021 Oct; 227():108927. PubMed ID: 34358766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with receipt of medication for opioid use disorder among pregnant individuals entering treatment programs in the U.S.
    Curran L; Manuel J
    Int J Drug Policy; 2024 Apr; 126():104342. PubMed ID: 38479161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biopsychosocial contexts of timely and adequate prenatal care utilization among women with criminal legal involvement and opioid use disorder.
    Satcher MF; Bruce ML; Goodman DJ; Lord SE
    BMC Public Health; 2023 Apr; 23(1):729. PubMed ID: 37085842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: Expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities.
    Gordon AJ; Drexler K; Hawkins EJ; Burden J; Codell NK; Mhatre-Owens A; Dungan MT; Hagedorn H
    Subst Abus; 2020; 41(3):275-282. PubMed ID: 32697170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions for incarcerated adults with opioid use disorder in the United States: A systematic review with a focus on social determinants of health.
    Sugarman OK; Bachhuber MA; Wennerstrom A; Bruno T; Springgate BF
    PLoS One; 2020; 15(1):e0227968. PubMed ID: 31961908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.